Covalent Ventures

www.covalent.ventures

VCMatch tracks Covalent Ventures as an investor focused on Foodtech, Healthtech, and Biotech companies, Growth rounds, and Global, Europe, and Asia markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Growth

Focus Areas

Foodtech, Healthtech, Biotech

Geography

Global, Europe, and Asia

Investment Thesis

Covalent Ventures operates as an impact-focused investor combining financial returns with real-world social impact. The firm believes in leveraging deep sector expertise and global networks to help companies scale into global brands, creating measurable impact in major markets. Their approach emphasizes “responsible investments” that generate returns while addressing food systems, nutrition, and healthcare challenges.

Is Covalent Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Covalent Ventures is most relevant for founders raising Growth rounds in Foodtech, Healthtech, Biotech, and Medtech, especially across Global, Europe, and Asia.

Focus statement

Covalent Ventures is a globally connected food and health impact investor providing growth stage companies with sector knowledge and extensive global networks to scale and compete in major global markets. They maintain coverage across food systems, nutrition, biotech/pharma, medical devices, digital health, healthcare systems, novel ingredients, and consumer packaged goods.

Value Add

Deep sector expertise across comprehensive food and health value chain
Immediate unfair advantage through active operational support and global networks
Founding partners' combined experience in biotech, healthcare, and CPG sectors with successful exits
Advisory team with C-suite experience at major multinationals (Bayer, DSM, Philips, McKinsey, Novartis, Roche)
Global coverage spanning Europe, Asia, and US markets